Prescription medication · ACE Inhibitor
moexipril
Also sold as Univasc. Moexipril is used to treat high blood pressure.
Data updated 2026-05-15
- 67
- FDA reportsRarely reported
- $0.88
- Generic price (NADAC)
moexipril (Univasc) is a prescription ACE Inhibitor. Moexipril is used to treat high blood pressure.
Moexipril is a medicine used to treat high blood pressure. It can be used alone or with a water pill.
Verify with FDA → · CMS NADAC pricing →
Drug Pricing (NADAC)
Generic Price
$0.88/unit
Generic Available
Yes (3 manufacturers)
Pricing data from NADAC (CMS), effective December 18, 2024. Compare all drug costs →
What it does
Moexipril is used to treat high blood pressure.
Common side effects
Cough, Dizziness, Diarrhea
Key warnings
This medicine can harm your unborn baby.
The sections below are summarized in plain English from moexipril's FDA-approved prescribing information. They describe what the official label says, and are not personal medical advice.
How It Works
Moexipril belongs to a class of drugs called ACE inhibitors. It works by blocking a substance in your body that tightens blood vessels. This helps your blood vessels relax and widens them, which lowers your blood pressure.
Side Effects (from patient reports)
Based on 67 FDA adverse event reports.
Most-reported reactions
Adverse reactions in FAERS for moexipril, by number of reports
- Asthenia
Asthenia
8 reports
- Dyspnoea
Dyspnoea
6 reports
- Nausea
Nausea
5 reports
- Blood Pressure Decreased
Blood Pressure Decreased
4 reports
- Cerebrovascular Accident
Cerebrovascular Accident
4 reports
- Cough
Cough
4 reports
- Dehydration
Dehydration
4 reports
- Diarrhoea
Diarrhoea
4 reports
- Flushing
Flushing
4 reports
- Headache
Headache
4 reports
What this shows Bars show how often each reaction was reported, not how likely it is to happen, a report records a temporal association, never proof that the drug caused it.
Reports over time
Adverse-event reports filed for moexipril each year to the FDA Adverse Event Reporting System (FAERS).
Year-to-year volume tracks usage, prescribing, and scrutiny, not a change in per-patient risk. Source: FDA FAERS.
Where moexipril sits
moexipril has more FDA adverse-event reports than 0% of the drugs FAERS tracks. A high position reflects how widely a drug is used and watched, not how dangerous it is.
Percentile across all drugs PlainMeds tracks by FAERS report volume. The dot is moexipril; the line is the median (50th percentile).
FDA Adverse Event Report Analysis
Detailed analysis of 67 reports from the FDA Adverse Event Reporting System (FAERS). Reports span 2004–2025.
Total Reports
67
Reports Mentioning Death
6
9.0% of reports — not proof of cause
Hospitalization Reports
21
Top Indication
Hypertension
Gender Distribution
Age Distribution
Most Reported Adverse Reactions (FAERS)
| # | Reaction | Reports |
|---|---|---|
| 1 | ASTHENIA | 8 |
| 2 | DYSPNOEA | 6 |
| 3 | NAUSEA | 5 |
| 4 | BLOOD PRESSURE DECREASED | 4 |
| 5 | CEREBROVASCULAR ACCIDENT | 4 |
| 6 | COUGH | 4 |
| 7 | DEHYDRATION | 4 |
| 8 | DIARRHOEA | 4 |
| 10 | FLUSHING | 4 |
| 11 | HEADACHE | 4 |
| 12 | HYPERTENSION | 4 |
| 13 | MALAISE | 4 |
| 14 | ARTHRALGIA | 3 |
| 15 | BLOOD PRESSURE INCREASED | 3 |
| 16 | DEATH | 3 |
Reactions in Death Reports
Reactions in Hospitalization Reports
Source: FDA FAERS (Adverse Event Reporting System) Reports are voluntary and do not establish causation
Serious Warnings
This medicine can harm your unborn baby. If you are pregnant or plan to become pregnant, tell your doctor right away. Stop taking moexipril as soon as you know you are pregnant.
Common Questions
What should I tell my doctor before taking moexipril?
Can I take moexipril if I am allergic to other medicines?
Does moexipril interact with other medications?
How long will I need to take moexipril?
Can I stop taking moexipril if my blood pressure is under control?
What should I do if I feel dizzy while taking moexipril?
Can moexipril cause kidney problems?
Is it safe to drink alcohol while taking moexipril?
Are there differences in how this medicine works in different races?
What are the signs of angioedema?
What are the common side effects of moexipril?
What drug class is moexipril?
What pregnancy or breastfeeding source fields are listed for moexipril?
Related Medications in ACE Inhibitor
Other drugs grouped near moexipril - same-class peers and common alternatives.
acebutolol
Sectral
Acebutolol is a medicine that helps lower blood pressure and control irregular heartbeats.
Compare with moexipril →
aliskiren
Tekturna
Tekturna is a medicine used to treat high blood pressure.
Compare with moexipril →
amiloride
Midamor
Amiloride is a water pill that helps your body hold onto potassium.
Compare with moexipril →
amlodipine
Norvasc
Amlodipine (Norvasc) is a drug that lowers blood pressure and treats chest pain.
Compare with moexipril →
amlodipine/benazepril
Lotrel
Lotrel is a combination medicine that contains amlodipine and benazepril.
Compare with moexipril →
Compare beyond drug class
Nationwide peers by FAERS volume & death-report share
Two PlainMeds-derived comparison paths for moexipril: nearest FDA FAERS report volume and nearest death-report share among drugs with at least 1,000 logged reports, excluding same-class neighbors listed above. Counts reflect reporting volume, not proven individual harm.
Similar FAERS report volume
Nearest drugs by total FAERS reports. This record: 67.
Similar death-report share
Nearest drugs by FAERS death-report share. This record: 8.96%.
- risedronate Δ 0.00 pts · 30,089 reports · Bisphosphonate 8.96%death share
- clomipramine Δ 0.03 pts · 4,403 reports · Tricyclic Antidepressant (TCA) 8.93%death share
- adenosine Δ 0.03 pts · 1,547 reports · Endogenous Nucleoside (Antiarrhythmic) 8.92%death share
- simvastatin Δ 0.04 pts · 245,754 reports · HMG-CoA Reductase Inhibitor (Statin) 8.92%death share
Medication Guides
Understanding Drug Interactions
How CYP450 enzymes, inhibitors, and inducers affect your medications
Generic vs Brand Name Drugs
FDA requirements, cost savings, and when the difference matters
Narrow Therapeutic Index Drugs
FDA bioequivalence and label-record context for narrow therapeutic index medicines
Common Drug Interactions
Dangerous medication combinations and how to protect yourself
Save on moexipril
Compare prices and find discounts at pharmacies near you. Free coupons can save up to 80% on prescriptions.
Disclosure: This link may earn us a commission at no extra cost to you. See our terms.
What the FDA Data Shows for moexipril
The FDA label for moexipril (sold under brand names such as Univasc) classifies it as a prescription-only medication in the ACE Inhibitor class. Moexipril is used to treat high blood pressure. Official labeling lists 9 commonly reported side effects, including Cough, Dizziness, Diarrhea.
Post-market surveillance from the FDA Adverse Event Reporting System (FAERS) captures real-world experience. For this drug, FAERS contains 67 voluntary reports. Interaction data is drawn directly from FDA-approved prescribing information. NADAC pricing from CMS shows a generic unit cost of $0.88.
Report counts do not establish causation, a FAERS entry documents a temporal association, not proof that the drug produced the outcome. Widely prescribed medications naturally accumulate more reports than niche therapies, so raw totals must be interpreted alongside total exposure. Shortage status, recall history, and patent information are separate source-record fields. This page is a public FDA/CMS registry and does not provide medical, treatment, substitution, or medication-change directions.
Data Sources
Drug labeling: FDA Drug Labels (SPL/DailyMed). Adverse events: FDA Adverse Event Reporting System (FAERS). Pricing: CMS National Average Drug Acquisition Cost (NADAC).
FAERS reports are voluntary and do not establish causation. Drug interactions are derived from FDA labeling and clinical references. This registry does not provide medication decisions.
Last updated: March 10, 2025
PlainMeds is rendered directly from FDA openFDA/FAERS extracts, DailyMed labels, and CMS drug-pricing files, no number is typed in by an editor. FAERS counts, recalls, shortages, and price figures on this page are queried live from those federal extracts. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-05-15. Primary sources: openFDA / FAERS, DailyMed and CMS Part B ASP.
Read our methodology - how this data is sourced, computed, and verified.
Data currency: FDA FAERS adverse-event reports through 2025, CMS NADAC acquisition-cost pricing effective December 2024, compiled from the source snapshot dated . See our methodology for per-source dates and refresh cadence. Spot a figure that looks wrong? Report a data issue.
All federal data sources used on this page
- FDA Orange Book - approved drug products with therapeutic equivalence. accessdata.fda.gov/cder/ob
- FDA DailyMed - NIH-hosted drug labeling for FDA-approved meds. dailymed.nlm.nih.gov
- FDA Adverse Event Reporting System (FAERS) - post-marketing safety surveillance. fda.gov/drugs/faers
- NLM RxNorm - standardized clinical drug nomenclature. nlm.nih.gov/research/umls/rxnorm
- CMS Medicare Part B Drug Average Sales Price Files - federal drug pricing data. cms.gov/medicare/part-b-drugs/asp
- FDA Drug Shortages Database - current and resolved drug shortage tracking. accessdata.fda.gov/drugshortages